{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:32:54Z","timestamp":1787319174216,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Research Board Ireland","award":["MRCG-2013-8"],"award-info":[{"award-number":["MRCG-2013-8"]}]},{"name":"Fighting Blindness Ireland","award":["FB16FAR"],"award-info":[{"award-number":["FB16FAR"]}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"crossref","award":["GOIPG\/2017\/1631"],"award-info":[{"award-number":["GOIPG\/2017\/1631"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["16\/1A\/4452"],"award-info":[{"award-number":["16\/1A\/4452"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Inherited retinal degenerations (IRD) are rare genetic disorders with\u2009&gt;\u2009300 known genetic loci, manifesting variably progressive visual dysfunction. IRDs were historically underserved due to lack of effective interventions. Many novel therapies will require accurate diagnosis (phenotype and genotype), thus an efficient and effective pathway for assessment and management is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using surveys of existing practice patterns and advice from international experts, an all-Ireland IRD service (Target 5000) was designed. Detailed phenotyping was followed by next generation genetic sequencing in both a research and accredited laboratory. Unresolved pedigrees underwent further studies (whole gene\/whole exome\/whole genome sequencing). Novel variants were interrogated for pathogenicity (cascade screening, in silico analysis, functional studies). A multidisciplinary team (MDT; ophthalmologists, physicians, geneticists, genetic counsellors) reconciled phenotype with genotype. A bespoke care plan was created for each patient comprising supports, existing interventions, and novel therapies\/clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>Prior to Target 5000, a significant cohort of patients were not engaged with healthcare\/support services due to lack of effective interventions. Pathogenic or likely pathogenic variants in IRD-associated genes were detected in 62.3%, with 11.6% having variants of unknown significance. The genotyping arm of Target 5000 allowed a 42.73% cost saving over independent testing, plus the value of MDT expertise\/processing. Partial funding has transferred from charitable sources to government resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Target 5000 demonstrates efficacious and efficient clinical\/genetic diagnosis, while discovering novel IRD-implicated genes\/variants and investigating mechanisms of disease and avenues of intervention. This model could be used to develop similar IRD programmes in small\/medium-sized nations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-01841-1","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T05:05:37Z","timestamp":1620191137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-7725","authenticated-orcid":false,"given":"Kirk A. J.","family":"Stephenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dockery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Duignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor P.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana","family":"Routledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Crossan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"O\u2019Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Kenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Jane","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"1841_CR1","unstructured":"Daiger SP. Summaries of genes and loci causing retinal diseases (RetNet). The University of Texas Health Science Center, Houston, Texas, 2020 [June 28, 2020]. https:\/\/sph.uth.edu\/retnet\/. Accessed 6 Sept 2020."},{"issue":"1","key":"1841_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0888-7543(90)90223-H","volume":"8","author":"GJ Farrar","year":"1990","unstructured":"Farrar GJ, McWilliam P, Bradley DG, Kenna P, Lawler M, Sharp EM, et al. Autosomal dominant retinitis pigmentosa: linkage to rhodopsin and evidence for genetic heterogeneity. Genomics. 1990;8(1):35\u201340.","journal-title":"Genomics"},{"issue":"3","key":"1841_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0888-7543(89)90031-1","volume":"5","author":"P McWilliam","year":"1989","unstructured":"McWilliam P, Farrar GJ, Kenna P, Bradley DG, Humphries MM, Sharp EM, et al. Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3. Genomics. 1989;5(3):619\u201322.","journal-title":"Genomics"},{"issue":"8","key":"1841_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/bjophthalmol-2012-302911","volume":"97","author":"R Combs","year":"2013","unstructured":"Combs R, Hall G, Payne K, Lowndes J, Devery S, Downes SM, et al. Understanding the expectations of patients with inherited retinal dystrophies. Br J Ophthalmol. 2013;97(8):1057\u201361.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1841_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/eye.2016.74","volume":"30","author":"M Eden","year":"2016","unstructured":"Eden M, Payne K, Jones C, Wright SJ, Hall G, McAllister M, et al. Identifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom. Eye (Lond). 2016;30(7):966\u201371.","journal-title":"Eye (Lond)"},{"issue":"2","key":"1841_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12687-014-0210-4","volume":"6","author":"M Harrison","year":"2015","unstructured":"Harrison M, Birch S, Eden M, Ramsden S, Farragher T, Payne K, et al. Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS. J Community Genet. 2015;6(2):157\u201365.","journal-title":"J Community Genet"},{"key":"1841_CR7","unstructured":"Black G. In: Keegan D, editor. 2014."},{"issue":"1","key":"1841_CR8","doi-asserted-by":"publisher","first-page":"e000462","DOI":"10.1136\/bmjophth-2020-000462","volume":"5","author":"PF Kenna","year":"2020","unstructured":"Kenna PF, Humphries MM, Kiang AS, Brabet P, Guillou L, Ozaki E, et al. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. BMJ Open Ophthalmol. 2020;5(1):e000462.","journal-title":"BMJ Open Ophthalmol"},{"issue":"9","key":"1841_CR9","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","volume":"26","author":"C Cukras","year":"2018","unstructured":"Cukras C, Wiley HE, Jeffrey BG, Sen HN, Turriff A, Zeng Y, et al. Retinal AAV8-RS1 gene therapy for X-linked retinoschisis: initial findings from a phase I\/IIa trial by intravitreal delivery. Mol Ther J Am Soc Gene Ther. 2018;26(9):2282\u201394.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"6","key":"1841_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/17469899.2019.1699406","volume":"14","author":"J Cehajic Kapetanovic","year":"2019","unstructured":"Cehajic Kapetanovic J, Patricio MI, MacLaren RE. Progress in the development of novel therapies for choroideremia. Expert Rev Ophthalmol. 2019;14(6):277\u201385.","journal-title":"Expert Rev Ophthalmol"},{"issue":"3","key":"1841_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","volume":"26","author":"J Cehajic-Kapetanovic","year":"2020","unstructured":"Cehajic-Kapetanovic J, Xue K, de la Camara CMF, Nanda A, Davies A, Wood LJ, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med. 2020;26(3):354\u20139.","journal-title":"Nat Med"},{"key":"1841_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaophthalmol.2020.1032","volume":"138","author":"MD Fischer","year":"2020","unstructured":"Fischer MD, Michalakis S, Wilhelm B, Zobor D, Muehlfriedel R, Kohl S, et al. Safety and vision outcomes of subretinal gene therapy targeting cone photoreceptors in achromatopsia: a nonrandomized controlled trial. JAMA Ophthalmol. 2020;138:643\u201351.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1841_CR13","doi-asserted-by":"publisher","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","volume":"4","author":"G Liew","year":"2014","unstructured":"Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16\u201364 years), 1999\u20132000 with 2009\u20132010. BMJ Open. 2014;4(2):e004015.","journal-title":"BMJ Open"},{"issue":"3","key":"1841_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"8","key":"1841_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/bjophthalmol-2014-305768","volume":"99","author":"KO Akuffo","year":"2015","unstructured":"Akuffo KO, Nolan J, Stack J, Moran R, Feeney J, Kenny RA, et al. Prevalence of age-related macular degeneration in the Republic of Ireland. Br J Ophthalmol. 2015;99(8):1037\u201344.","journal-title":"Br J Ophthalmol"},{"key":"1841_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/OPTH.S241928","volume":"14","author":"O Galvin","year":"2020","unstructured":"Galvin O, Chi G, Brady L, Hippert C, Del Valle RM, Daly A, et al. The impact of inherited retinal diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a cost-of-illness perspective. Clin Ophthalmol (Auckland, NZ). 2020;14:707\u201319.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"2","key":"1841_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.exer.2004.03.005","volume":"79","author":"BJ Seyedahmadi","year":"2004","unstructured":"Seyedahmadi BJ, Rivolta C, Keene JA, Berson EL, Dryja TP. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res. 2004;79(2):167\u201373.","journal-title":"Exp Eye Res"},{"issue":"2","key":"1841_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/eop.11.2","volume":"6","author":"JE Sutherland","year":"2011","unstructured":"Sutherland JE, Day MA. Advantages and disadvantages of molecular testing in ophthalmology. Expert Rev Ophthalmol. 2011;6(2):221\u201345.","journal-title":"Expert Rev Ophthalmol"},{"key":"1841_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13023-018-0980-6","volume":"14","author":"PI Sergouniotis","year":"2019","unstructured":"Sergouniotis PI, Maxime E, Leroux D, Olry A, Thompson R, Rath A, et al. An ontological foundation for ocular phenotypes and rare eye diseases. Orphanet J Rare Dis. 2019;14:8.","journal-title":"Orphanet J Rare Dis"},{"key":"1841_CR20","unstructured":"Orphanet. Orphanet rare disease nomenclature 2018 [cited 2018 April 30]. http:\/\/www.orpha.net\/consor\/cgi-bin\/index.php?lng=EN. Accessed 9 Sept 2020."},{"issue":"5","key":"1841_CR21","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405\u201324.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"1841_CR22","unstructured":"ERN-EYE. Eye diseases (ERN-EYE) 2018 [cited 2018, May 2]. https:\/\/www.ern-eye.eu\/. Accessed 15 Sept 2020."},{"issue":"10097","key":"1841_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet (London, England). 2017;390(10097):849\u201360.","journal-title":"Lancet (London, England)"},{"issue":"11","key":"1841_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/genes8110304","volume":"8","author":"A Dockery","year":"2017","unstructured":"Dockery A, Stephenson K, Keegan D, Wynne N, Silvestri G, Humphries P, et al. Target 5000: Target Capture Sequencing For Inherited Retinal Degenerations. Genes. 2017;8(11):304.","journal-title":"Genes"},{"issue":"R1","key":"1841_CR25","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1093\/hmg\/ddx185","volume":"26","author":"GJ Farrar","year":"2017","unstructured":"Farrar GJ, Carrigan M, Dockery A, Millington-Ward S, Palfi A, Chadderton N, et al. Toward an elucidation of the molecular genetics of inherited retinal degenerations. Hum Mol Genet. 2017;26(R1):R2-r11.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1841_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/genes11010105","volume":"11","author":"L Whelan","year":"2020","unstructured":"Whelan L, Dockery A, Wynne N, Zhu J, Stephenson K, Silvestri G, et al. Findings from a genotyping study of over 1000 people with inherited retinal disorders in Ireland. Genes. 2020;11(1):105.","journal-title":"Genes"},{"key":"1841_CR27","doi-asserted-by":"publisher","first-page":"33248","DOI":"10.1038\/srep33248","volume":"6","author":"M Carrigan","year":"2016","unstructured":"Carrigan M, Duignan E, Malone CP, Stephenson K, Saad T, McDermott C, et al. Panel-based population next-generation sequencing for inherited retinal degenerations. Sci Rep. 2016;6:33248.","journal-title":"Sci Rep"},{"key":"1841_CR28","first-page":"1235","volume":"22","author":"M Khan","year":"2020","unstructured":"Khan M, Cornelis SS, Pozo-Valero MD, Whelan L, Runhart EH, Mishra K, et al. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics. Genet Med Off J Am Coll Med Genet. 2020;22:1235\u201346.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"1","key":"1841_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","volume":"100","author":"KJ Carss","year":"2017","unstructured":"Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100(1):75\u201390.","journal-title":"Am J Hum Genet"},{"key":"1841_CR30","unstructured":"Duncan JLBPS, Birch DG, Fishman GA, Heon E, Jacobson SG, Pennesi ME, Pierce EA, Scholl HP, Stone EM, Trzupek K, Weleber RG. Recommendations on clinical assessment of patients with inherited retinal degenerations\u20142016. USA: American Academy of Ophthalmology; 2016. https:\/\/www.aao.org\/clinical-statement\/recommendations-on-clinical-assessment-of-patients. Accessed 3 Nov 2020."},{"key":"1841_CR31","unstructured":"Floyd G. ECLO impact tool: UK wide findings 2015\u20132016: Royal National Institute of Blind People; 2016 [cited 2018 April 8]. http:\/\/www.rnib.org.uk\/professionals\/knowledge-and-research-hub\/research-reports\/early-reach-research\/ECLO-impact-tool. Accessed 17 Sept 2020."},{"issue":"9","key":"1841_CR32","first-page":"401","volume":"60","author":"OAR Mahroo","year":"2019","unstructured":"Mahroo OAR, Pontikos N, Arno G, Ba-Abbad R, Malka S, Wright G, et al. Genetic basis of inherited retinal disease in a UK cohort of over 2900 families. Investig Ophthalmol Vis Sci. 2019;60(9):401.","journal-title":"Investig Ophthalmol Vis Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01841-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T20:05:46Z","timestamp":1620245146000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01841-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"1 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review boards of the Mater Misericordiae University Hospital, Dublin, Ireland, the Royal Victoria Eye and Ear Hospital, Dublin, Ireland and the Belfast Health and Social Care Trust Hospitals, Belfast, Northern Ireland. All subjects whose data is included in this manuscript signed informed consent before participation in the Target 5000 study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects whose data is included in this manuscript signed informed consent allowing anonymised use of their data in scientific publications.All subjects whose data is included in this manuscript signed informed consent allowing anonymised use of their data in scientific publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare relevant to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}